文献速递妇科

晚期卵巢癌理想减灭术后术者残留病变评估与影像学评估的一致性:NRG肿瘤/妇科肿瘤组研究

Correlation between Surgeon's assessment and radiographic evaluation of residual disease in women with advanced stage ovarian cancer reported to have undergone optimal surgical cytoreduction: An NRG Oncology/Gynecologic Oncology Group study.
PubMed 文献 · Gynecol Oncol · 2018-03-15

该研究为一项3期随机临床试验的事后分析,纳入627例晚期卵巢癌理想减灭术(残留病变≤1cm)患者,比较术者术中评估与化疗前CT所见。40%患者术后CT显示残留病变>1cm,此类不一致患者疾病进展风险显著更高(HR 1.30;95%CI 1.08-1.56;p=0.0059)。

要点

  • 40%报告理想减灭的患者术后CT显示残留病变>1cm。
  • 残留病变>1cm最常见于右上腹(28.4%)、腹膜后腹主动脉旁淋巴结(>1.5cm;28.2%)和左上腹(10.7%)。
  • CT与术者评估不一致者疾病进展风险显著更高(HR 1.30;95%CI 1.08-1.56;p=0.0059)。

核心结论

  • 在报告接受理想减灭术的患者中,40%术后化疗前影像发现>1cm病灶。
  • 炎症改变和/或肿瘤快速再生长可解释不一致,但对PFS的影响和残留病变分布可能提示术者低估。

研究设计与样本

  • 该研究为一项评估贝伐珠单抗在晚期卵巢癌手术减灭后一线及维持治疗作用的3期随机临床试验的事后分析。
  • 1873例入组患者中639例手术结果为理想(残留病变≤1cm),排除12例无基线治疗前影像者,最终627例纳入分析。
  • 手术至基线扫描平均间隔26天(范围1-109天)。

主要发现

  • 251例(40%)术后扫描与术者评估不一致,显示残留病变>1cm。
  • 残留病变>1cm最常见于右上腹(28.4%)、腹膜后腹主动脉旁淋巴结(>1.5cm;28.2%)和左上腹(10.7%)。
  • 治疗前CT显示残留病变>1cm(不一致)的患者疾病进展风险显著更高(HR 1.30;95%CI 1.08-1.56;p=0.0059)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We sought to determine the level of concordance among surgeons' assessment of residual disease (RD) and pre-treatment computed tomography (CT) findings among women who underwent optimal surgical cytoreduction for advanced stage ovarian cancer. METHODS: This is a post-trial ad hoc analysis of a phase 3 randomized clinical trial evaluating the impact of bevacizumab in primary and maintenance therapy for patients with advanced stage ovarian cancer following surgical cytoreduction. All subjects underwent imaging of the chest/abdomen/pelvis to establish a post-surgical baseline prior to the initiation of chemotherapy. Information collected on trial was utilized to compare surgeon's operative assessment of RD, to pre-treatment imaging. RESULTS: Of 1873 enrolled patients, surgical outcome was described as optimal (RD≤1cm) in 639 subjects. Twelve patients were excluded as they did not have a baseline, pretreatment imaging, leaving 627 participants for analysis. The average interval from surgery to baseline scan was 26days (range: 1-109). In 251 cases (40%), the post-operative scan was discordant with surgeon assessment, demonstrating RD>1cm in size. RD>1cm was most commonly identified in the right upper quadrant (28.4%), retroperitoneal para-aortic lymph nodes (RD>1.5cm; 28.2%) and the left upper quadrant (10.7%). Patients with RD>1cm on pre-treatment CT (discordant) exhibited a significantly greater risk of disease progression (HR 1.30; 95% CI 1.08-1.56; p=0.0059). CONCLUSIONS: Among patients reported to have undergone optimal cytoreduction, 40% were found to have lesions >1cm on postoperative, pretreatment imaging. Although inflammatory changes and/or rapid tumor regrowth could account for the discordance, the impact on PFS and distribution of RD may suggest underestimation by the operating surgeon.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Eskander RN, Kauderer J, Tewari KS, et al. Correlation between Surgeon's assessment and radiographic evaluation of residual disease in women with advanced stage ovarian cancer reported to have undergone optimal surgical cytoreduction: An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2018. PMID: 29550184. doi:10.1016/j.ygyno.2018.03.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。